By continuing to use the site, you will be treated as having given your consent for processing your personal data: cookies and user data using the Yandex.Metrika and liveinternet.ru metric programs to improve the site and for the purpose of statistical analysis. If you do not want your data to be processed, please leave the site
RU
Sun Pharma announced the launch of a new drug Faringospray®
17 июля 2023
Sun Pharma announced the launch of a new drug Faringospray®
Commercial production of the spray for a sore throat under the trade name “Faringospray®” was launched this year in June by Biosintez PJSC (the Sun Pharma manufacturing site in Russia)
Faringospray® is a new product in the category of throat soothers and anti-inflammatory agents from Sun Pharma. The drug complements the line of the famous Faringosept® brand which has been on the market for more than 40 years. Faringospray® contains the benzydamine active agent and is recommended as symptomatic treatment for pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiologies), such as: gingivitis, glossitis, stomatitis (including after radiation and chemotherapy); pharyngitis, laryngitis, tonsillitis; candidiasis of the oral mucosa (as part of combined modality treatment); calculous inflammation of the salivary glands; after surgical interventions and injuries (tonsillectomy, jaw fractures); after treatment and tooth extraction; periodontal disease.